Preventing migraine chronification and medication overuse headache requires decreasing the number of migraine attacks and ...

Eptinezumab vs placebo significantly reduces acute headache medication in patients with migraine and those with medication overuse.

No new safety signals emerged after concomitant atogepant plus ubrogepant in patients with atogepant-refractory episodic migraine.

Once in a while, we all get a headache. And 70% of the time, it’s caused by stress and tension. Most people will pop a painkiller and hope the pain goes away quickly. But for migraine sufferers ...

Mind+ Neurology is advancing medical research and offering hope to patients living with migraine. Mind+ is an authorized site for a new Episodic Migraine clinical trial.

There are more than 150 different types of headaches, ranging from a mild annoyance to a debilitating experience. Here's how ...

You can also refer to this Ubrelvy overview article for details. Ubrelvy is approved for the immediate treatment of migraine in adults. The drug isn’t approved to prevent migraine episodes from ...

The U.S. Food and Drug Administration has expanded the age indication for Theranica's Nerivio, making it the first and only remote electrical neuromodulation (REN) wearable for migraine treatment ...

Vasodilator drugs that block the calcitonin gene ... the initiation of this painful process could provide a new avenue of hope for migraine sufferers. More information: Hyeonwi Son et al, PACAP38 ...

The pain may start out as mild. But without treatment, it can become moderate to severe. Migraine pain most commonly affects the forehead area. It’s usually on one side of the head but can occur ...

Nerivio is a wireless remote electrical neuromodulation device that is self-applied to the upper arm. Among pediatric patients with available data, 72.2% (13/18) reported consistent headache ...